from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1580c/-

LFCtreatmentdescriptionclass of inhibitor

1.026

Amikacinug/mL Amikacintranslation

0.094

Cap5-10ug/mL Capreomycintranslation

0.095

Rox10-50 ug/mL Roxithromycintranslation

-0.570

SM2-5 ug/mL Streptomycintranslation

-0.094

Tet5-10 ug/mL Tetracyclinetranslation

-0.396

Rif0.2-5ug/mL Rifampicintranscription

0.348

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.026

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.240

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.197

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.080

Clofazimine10-13 ug/mL Clofaziminerespiration

0.071

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

4.064

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.821

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.938

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.613

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.856

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.690

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.843

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.748

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.454

KCN5-20 ug/mL Potassium cyaniderespiration

-0.839

NaN30.2-2 mM Sodium aziderespiration

0.380

Nigericin50 uM Nigericinrespiration

0.171

TRC10-150 ug/mL Triclosanrespiration

-0.812

TRZ10-25 ug/mL Thioridazinerespiration

0.767

Valinomycin0.5-10 uM Valinomycinrespiration

1.089

ZnSO42 mM ZnSO4respiration

-0.035

menadione6-10 ug/mL Menadionerespiration

-0.786

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.147

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.235

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.175

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.263

NRP_1Non-replicating persistence stage 1dosRassociated

-0.031

Amp0.2mg/mL AmpicillincellWall

0.266

Cephalexin20-100 ug/mL CephalexincellWall

-0.203

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.008

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.300

EMB10-20 ug/mL EthambutolcellWall

0.262

Eta12-40 ug/mL EthionamidecellWall

-0.525

INH0.2-0.4 ug/mL IsoniazidcellWall

0.447

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.522

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.737

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.417

BZA0.12 mg/mL BenzamidearomaticAmides

-0.581

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.494

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.463

H2O24 mM hydrogen peroxideDNAdamaging

0.015

Levo10 ug/mL LevofloxacinDNAdamaging

0.123

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.235

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.233

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.582

UVUV-irradiationDNAdamaging

0.171

ARP41-4 ug/mL Antitubercular compound ARP4?

0.359

Antimycin12.5-50 ug/mL Antimycin A?

0.029

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.039

PA_110-50 ug/mL Antitubercular compound PA-1?

0.867

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.497

PA8240.2-2 ug/mL PA-824?

-0.494

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.673

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.149

Verapamil50 uM Verapamil?

0.716

mercaptoethanol2 mM 2-Mercaptoethanol?

0.485

methoxatin10-20 ug/mL Methoxatin?